Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4266983 | Transplantation Reviews | 2009 | 8 Pages |
Abstract
Interleukin (IL) 17 is a proinflammatory cytokine already known to play a defense role against microbes and a pathogenic role in a number of autoimmune diseases. Although IL-17 can be produced by a variety of cells including neutrophils, CD8+, NK, and gamma-delta T cells, the concept of IL-17–secreting CD4+ T helper cells (Th17), distinct from Th1 and Th2, recently emerged. Herein, we discuss arguments in favor of a Th17-mediated alternative pathway of allograft rejection based on clinical and experimental observations drawn from the literature. We also discuss the complex interplays among regulatory T cells and Th17 cells in the allogeneic context.
Related Topics
Health Sciences
Medicine and Dentistry
Transplantation
Authors
Fleur Samantha Benghiat, Louis Marie Charbonnier, Benoit Vokaer, Virginie De Wilde, Alain Le Moine,